Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for Primary Interviews in North America
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.3. Competitive Insights
Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of acute ischemic strokes
3.4.1.2. Introduction of technologically advanced products
3.4.1.3. Rising Adoption of Unhealthy Lifestyle
3.4.2. Market Restraint Analysis
3.4.2.1. Stringent and complex regulatory framework
3.4.2.2. Risks associated with the neurothrombectomy devices
3.5. Neurothrombectomy Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. U.S. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Neurothrombectomy Devices Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Clot Retrievers
4.4.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Aspiration/Suction Devices
4.4.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Vascular Snares
4.4.3.1. Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Neurothrombectomy Devices Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Hospital
5.4.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Emergency Clinics
5.4.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Ambulatory Surgical Centers
5.4.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2023
6.3.4. Medtronic
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Acandis GmbH
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Phenox GmbH
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Stryker
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Penumbra, Inc.
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Vesalio
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.S. neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Neurothrombectomy devices market: market outlook
Fig. 9 Neurothrombectomy devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Neurothrombectomy devices market driver impact
Fig. 15 Neurothrombectomy devices market restraint impact
Fig. 16 Neurothrombectomy devices market strategic initiatives analysis
Fig. 17 Neurothrombectomy devices market: product movement analysis
Fig. 18 Neurothrombectomy devices market: product outlook and key takeaways
Fig. 19 Clot retrievers market estimates and forecast, 2018 - 2030
Fig. 20 Aspiration/Suction devices market estimates and forecast, 2018 - 2030
Fig. 21 Vascular Snares market estimates and forecast, 2018 - 2030
Fig. 22 Neurothrombectomy devices market: end use movement analysis
Fig. 23 Neurothrombectomy devices market: end use outlook and key takeaways
Fig. 24 Hospital market estimates and forecast, 2018 - 2030
Fig. 25 Emergency clinics market estimates and forecast, 2018 - 2030
Fig. 26 Ambulatory surgical centers market estimates and forecast, 2018 - 2030
Fig. 27 Participant categorization- Neurothrombectomy devices market
Fig. 28 Market share of key market players- Neurothrombectomy devices market